Caring Brands (CABR) Debt Ratio (2025)
Caring Brands' (CABR) quarterly Debt Ratio came in at 0.03 in Q4 2025, down 39.11% quarter-over-quarter from 0.04 in Q3 2025.
Caring Brands (CABR) Debt Ratio (2025) Analysis & Trends
Caring Brands' Debt Ratio history runs 1 years deep, the most recent figure standing at 0.03 for Q4 2025.
- On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.03 in Q4 2025; TTM through Dec 2025 was 0.03, a N/A change from a year earlier, with the FY2025 full-year figure at 0.03, changed N/A from the prior year.
- Debt Ratio eased to 0.03 in Q4 2025 per CABR's latest filing, from 0.04 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.04 in Q3 2025 and bottomed at 0.03 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 0.26 |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.42 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.29 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 0.10 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.29 |
| 10 | Caring Brands | 20.08 Mn | 21.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.03 |
| Sep 30, 2025 | 0.04 |